The table(s) below describe apps and devices that are integrated with FreeStyle Libre technology, along with country availability.
FreeStyle LibreLink¹ is compatible with NovoPen® 6 and NovoPen Echo® Plus.
App integration approved in:
Australia, Austria, Belgium, Canada (FreeStyle Libre 2 app), Croatia, Czech Republic, Denmark, Finland, France, Greece, Ireland, Italy, Japan, Luxembourg, Netherlands, Norway, Poland, Portugal, Slovakia, Slovenia, Spain, Sweden, Switzerland and the United Kingdom
FreeStyle Libre 3 is authorized to work with the mylife Loop automated insulin delivery system, including the mylife CamAPS FX app and mylife YpsoPump insulin pump.
For use of FreeStyle Libre 3 sensor with the mylife Loop, refer to the labeling provided with the mylife CamAPS FX app
Available in:
Austria, Belgium, Finland, Germany, Italy, Netherlands, Norway, Spain, Sweden, Switzerland and the United Kingdom
FreeStyle Libre 3 Plus is authorized to work with the mylife Loop automated insulin delivery system, including the mylife CamAPS FX app and mylife YpsoPump insulin pump.
For use of FreeStyle Libre 3 Plus sensor with the mylife Loop, refer to the labeling provided with the mylife CamAPS FX app
Available in:
Germany, Italy, New Zealand
FreeStyle Libre 2 Plus sensor is authorized to work with the Omnipod® 5 Automated Insulin Delivery System.
Available in:
Netherlands, United Kingdom
FreeStyle Libre 2 Plus sensor is authorized to work with the Tandem t:slim X2 insulin pump
Available in:
United States
Abbott’s FreeStyle Libre 14-day system and its digital health tools, including the FreeStyle LibreLink mobile app¹ and LibreView² cloud-based software, are integrated into Omada Health’s proprietary digital coaching platform.
Available in:
United States
This list will be updated as other devices, apps, software and systems are evaluated by Abbott Diabetes Care. Use of your Sensor with devices, apps, software and systems that are not listed may cause inaccurate glucose readings.
1. The FreeStyle LibreLink app is only compatible with certain mobile devices and operating systems. Please check the website for more information about device compatibility before using the app. Use of the FreeStyle LibreLink app may require registration with LibreView.
2. The LibreView data management software is intended for use by both patients and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis and evaluation of historical glucose meter data to support effective diabetes management. The LibreView software is not intended to provide treatment decisions or to be used as a substitute for professional healthcare advice
NovoPen® 6 and NovoPen Echo® Plus smart insulin pens may not be available in all countries.
The sensor housing, FreeStyle, Libre and related brand marks are marks of Abbott. NovoPen® 6 and NovoPen Echo® Plus are registered trademarks owned by Novo Nordisk. mylife and YpsoPump are registered trademarks of Ypsomed AG. CamAPS is a registered trademark of CamDiab Ltd. Omnipod is a registered trademark of Insulet Corporation and used with permission. Other trademarks are the property of their respective owners.
ADC-71912 v11.0
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimized for your screen size.
